396 related articles for article (PubMed ID: 27926553)
1. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest.
Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML
Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553
[TBL] [Abstract][Full Text] [Related]
2. Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer.
Young JI; Mongoue-Tchokote S; Wieghard N; Mori M; Vaccaro GM; Sheppard BC; Tsikitis VL
Dis Colon Rectum; 2016 Apr; 59(4):306-15. PubMed ID: 26953989
[TBL] [Abstract][Full Text] [Related]
3. Trends in lymph node excision and impact of positive lymph node ratio in patients with colectomy for primary colon adenocarcinoma: Population based study 1988 to 2011.
Garcia B; Guzman C; Johnson C; Hellenthal NJ; Monie D; Monzon JR
Surg Oncol; 2016 Sep; 25(3):158-63. PubMed ID: 27566017
[TBL] [Abstract][Full Text] [Related]
4. Impact of Tumor Deposits on Oncologic Outcomes in Stage III Colon Cancer.
Wong-Chong N; Motl J; Hwang G; Nassif GJ; Albert MR; Monson JRT; Lee L
Dis Colon Rectum; 2018 Sep; 61(9):1043-1052. PubMed ID: 30086053
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic colectomy for cancer: Improved compliance with guidelines for chemotherapy and survival.
Kim RH; Kavanaugh MM; Caldito GC
Surgery; 2017 Jun; 161(6):1633-1641. PubMed ID: 28027818
[TBL] [Abstract][Full Text] [Related]
6. Examining the relationship between lymph node harvest and survival in patients undergoing colectomy for colon adenocarcinoma.
Trepanier M; Erkan A; Kouyoumdjian A; Nassif G; Albert M; Monson J; Lee L
Surgery; 2019 Oct; 166(4):639-647. PubMed ID: 31399220
[TBL] [Abstract][Full Text] [Related]
7. Quality of care along the cancer continuum: does receiving adequate lymph node evaluation for colon cancer lead to comprehensive postsurgical care?
Parsons HM; Tuttle TM; Kuntz KM; Begun JW; McGovern PM; Virnig BA
J Am Coll Surg; 2012 Sep; 215(3):400-11. PubMed ID: 22683070
[TBL] [Abstract][Full Text] [Related]
8. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Effect of Ultra-Staging Node-Negative Colon Cancer Without Adjuvant Chemotherapy: A Prospective National Cancer Institute-Sponsored Clinical Trial.
Protic M; Stojadinovic A; Nissan A; Wainberg Z; Steele SR; Chen DC; Avital I; Bilchik AJ
J Am Coll Surg; 2015 Sep; 221(3):643-51; quiz 783-5. PubMed ID: 26213360
[TBL] [Abstract][Full Text] [Related]
10. Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?
Lee L; Erkan A; Alhassan N; Kelly JJ; Nassif GJ; Albert MR; Rt Monson J
Surg Oncol; 2018 Sep; 27(3):449-455. PubMed ID: 30217301
[TBL] [Abstract][Full Text] [Related]
11. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
[TBL] [Abstract][Full Text] [Related]
12. Hospital lymph node examination rates and survival after resection for colon cancer.
Wong SL; Ji H; Hollenbeck BK; Morris AM; Baser O; Birkmeyer JD
JAMA; 2007 Nov; 298(18):2149-54. PubMed ID: 18000198
[TBL] [Abstract][Full Text] [Related]
13. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
Ejaz A; Casadaban L; Maker AV
J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
[TBL] [Abstract][Full Text] [Related]
14. A critical appraisal of treatment for T3N0 colon cancer.
Yo IS; Opelka FG; Bolton JS; Fuhrman GM
Am Surg; 2001 Feb; 67(2):143-8. PubMed ID: 11243538
[TBL] [Abstract][Full Text] [Related]
15. Hospital Variability in Use of Adjuvant Chemotherapy for Patients with Stage 2 and 3 Colon Cancer.
Daly MC; Hanseman DJ; Abbott DE; Shah SA; Paquette IM
Dis Colon Rectum; 2016 Dec; 59(12):1134-1141. PubMed ID: 27824698
[TBL] [Abstract][Full Text] [Related]
16. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined.
Swanson RS; Compton CC; Stewart AK; Bland KI
Ann Surg Oncol; 2003; 10(1):65-71. PubMed ID: 12513963
[TBL] [Abstract][Full Text] [Related]
17. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
18. Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.
van den Broek CB; Bastiaannet E; Dekker JW; Portielje JE; de Craen AJ; Elferink MA; van de Velde CJ; Liefers GJ; Kapiteijn E
Acta Oncol; 2013 Jun; 52(5):941-9. PubMed ID: 23145507
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Chemotherapy Is Associated with Lower Lymph Node Counts in Colon Cancer.
Mullen MG; Shah PM; Michaels AD; Hassinger TE; Turrentine FE; Hedrick TL; Friel CM
Am Surg; 2018 Jun; 84(6):996-1002. PubMed ID: 29981638
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer.
Mayanagi S; Kashiwabara K; Honda M; Oba K; Aoyama T; Kanda M; Maeda H; Hamada C; Sadahiro S; Sakamoto J; Saji S; Yoshikawa T
Dis Colon Rectum; 2018 Jul; 61(7):803-808. PubMed ID: 29561282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
